Method and compositions for the treatment and prevention of septic shock
US5055447A · kind A · utility
44Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 1989 |
| Grant date | Oct 8, 1991 |
| Priority date | — |
| Expiry date | Jun 27, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are provided for the treatment or prophylaxis of septic shock caused by bacteremic infection. Therapeutically and prophylactically effective doses of transforming growth factor-beta are administered to patients, either alone or in combination with another therapeutic or prophylactic agent for treating this pathologic condition. Preferably, the transforming growth factor-beta is human transforming growth factor-beta, and most preferably TGF-.beta..sub.1, TGF-.beta..sub.2, or TGF-.beta..sub.3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.